Xencor, Inc.
USD11.21
-0.59 (-5.00%)
CEO
Bassil I. Dahiyat
IPO Date
2013-12-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$11.61
Prev. Close
$11.80
Day Low
$11.07
Day High
$11.67
52W Low
$6.92
52W High
$18.69
Market Cap
$0.83B
Volume
0.57M
| 4,118 |
| $11.25 |
| 9 Mar 2026 | Desjarlais John R | SR. VICE PRESIDENT & CSO | S-Sale | Disposed | 2,502 | $11.02 |
| 9 Mar 2026 | Eckert Celia | SVP, GENERAL COUNSEL | S-Sale | Disposed | 3,244 | $11.25 |
| 9 Mar 2026 | Eckert Celia | SVP, GENERAL COUNSEL | S-Sale | Disposed | 1,767 | $11.02 |
| 9 Mar 2026 | Cornelissen Bart Jan | SR. VICE PRESIDENT & CFO | S-Sale | Disposed | 2,517 | $11.25 |
| 9 Mar 2026 | Dahiyat Bassil I | director, officer: PRESIDENT & CEO | S-Sale | Disposed | 14,870 | $11.25 |
| 9 Mar 2026 | Dahiyat Bassil I | director, officer: PRESIDENT & CEO | S-Sale | Disposed | 6,606 | $11.02 |
| 4 Mar 2026 | Desjarlais John R | SR. VICE PRESIDENT & CSO | S-Sale | Disposed | 2,663 | $11.90 |
| 4 Mar 2026 | Desjarlais John R | SR. VICE PRESIDENT & CSO | A-Award | Acquired | 149,440 | $12.30 |